drugset / Trial / NCT02342275

Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma

NCT02342275

Phase 3 Completed 377 enrolled West China Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to compare the efficacy of orally administered propranolol versus atenolol in the treatment of potentially disfiguring or functionally threatening IHs.

Timeline

Start
2013-10
Primary completion
2018-09
Completion
2018-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atenolol Other / unclassified 1 mg/kg Oral
Comparator Propranolol Small molecule 2 mg/kg Oral

Indications